Status
Terminated
Drug Enforcement D-0056-2024
Lack of Assurance of Sterility
Classification
Class II
Report Date
October 25, 2023
Termination Date
May 15, 2024
Product Information
- Product description
- Moxifloxacin in Balanced Salt Solution, Solution for Intraocular Injection, 600 mcg/0.4mL (150 mcg/0.1mL) Syringe, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
- Product quantity
- 2484 syringes
- Reason for recall
- Lack of Assurance of Sterility
- Recall initiation reason
- —
- Initial firm notification
- Letter
- Distribution pattern
- Nationwide within the United States
Location & Firm
- Recalling firm
- Pine Pharmaceuticals, LLC
- Address
-
355 Riverwalk Pkwy, N/A
United States - Voluntary / Mandated
- Voluntary: Firm initiated
- Status date
- —
Codes & Dates
- Recall number
- D-0056-2024
- Event ID
- 93154
- Recall initiation date
- October 2, 2023
- Center classification date
- October 19, 2023
- Code info
- Lot #: 67480, Exp. Date 10/9/2023; 68640,Exp. Date 12/3/2023; 68769, Exp. Date 12/9/2023; 68760, Exp. Date 12/10/2023; 68925, Exp. Date 12/16/2023;70119, Exp. Date 1/20/2024
- More code info
- —